UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

Annals of oncology, 2005-07, Vol.16 (7), p.1081-1086

2005

Volltextzugriff (PDF)

Biological impacts of oil pollution and cleaning in the intertidal zone of exposed sandy beaches: Preliminary study of the “Prestige” oil spill

Estuarine, coastal and shelf science, 2005-10, Vol.65 (1), p.19-29

2005

Volltextzugriff (PDF)

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

Journal of clinical oncology, 2001-11, Vol.19 (21), p.4097-4106

2001

Volltextzugriff (PDF)

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

Annals of oncology, 2017-06, Vol.28 (6), p.1294-1301

2017

Volltextzugriff (PDF)

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

BMC cancer, 2019-06, Vol.19 (1), p.533-9, Article 533

2019

Volltextzugriff (PDF)

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Annals of oncology, 2003-11, Vol.14 (11), p.1640-1647

2003

Volltextzugriff (PDF)

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer

Annals of oncology, 2015-03, Vol.26 (3), p.535-541

2015

Volltextzugriff (PDF)

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy

Annals of oncology, 2019-03, Vol.30 (3), p.439-446

2019

Volltextzugriff (PDF)

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial

Annals of oncology, 2019-05, Vol.30 (5), p.796-803

2019

Volltextzugriff (PDF)

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

Clinical & translational oncology, 2015-12, Vol.17 (12), p.972-981

2015

Volltextzugriff (PDF)

The macroinfauna of the Galician sandy beaches (NW Spain) affected by the Prestige oil-spill

Marine pollution bulletin, 2005-05, Vol.50 (5), p.526-536

2005

Volltextzugriff (PDF)

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

Scientific reports, 2019-02, Vol.9 (1), p.2589-2589, Article 2589

2019

Volltextzugriff (PDF)

Macroinfaunal recovery on the beach most severely affected by the ‘Prestige’ oil spill (O Rostro, Galicia, north-west Spain)

Journal of the Marine Biological Association of the United Kingdom, 2014-02, Vol.94 (1), p.17-24

2014

Volltextzugriff (PDF)

P17.35 GEINO-10: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY OF THE CHARACTERISTICS OF PATIENTS WITH INTRA-AXIAL BRAIN TUMOURS AND THEIR THERAPEUTIC MANAGEMENT IN SPANISH HOSPITALS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii95-ii95

2014

Volltextzugriff (PDF)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer

Clinical & translational oncology, 2015-05, Vol.17 (5), p.384-392

2015

Volltextzugriff (PDF)

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003, Vol.39 (1), p.77-84

2003

Volltextzugriff (PDF)

CP-117 Use and effectiveness of firstline chemotherapy regimens in advanced gastric cancer: evolution from 2009 to 2016

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A52-A52

2017

Volltextzugriff (PDF)

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

Annals of oncology, 2018-02, Vol.29 (2), p.439-444

2018

Volltextzugriff (PDF)

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

Breast cancer research and treatment, 1999-11, Vol.58 (2), p.141-150

1999

Volltextzugriff (PDF)

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

European journal of cancer (1990), 2022-12, Vol.177, p.154-163

2022

Volltextzugriff (PDF)

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

Breast cancer research and treatment, 2000-07, Vol.62 (2), p.127-133

2000

Volltextzugriff (PDF)

High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas : benefit for selected patients

Bone marrow transplantation (Basingstoke), 1996-07, Vol.18 (1), p.143-150

1996

Volltextzugriff (PDF)

First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii183

2018

Volltextzugriff (PDF)

P897Sacubitril/valsartan: science-fiction, or current practice?

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P3611Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(114)
Humans
(69)
Male
(48)
Female
(47)
Biological And Medical Sciences
(42)
Physical Sciences
(42)
Aged
(41)
Middle Aged
(40)
Oncology
(36)
Adult
(35)
Medical Sciences
(30)
Pharmacology. Drug Treatments
(28)
Chemotherapy
(27)
Animals
(26)
Physics
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Antineoplastic Agents
(19)
Plant Sciences
(17)
Treatment Outcome
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

Biological impacts of oil pollution and cleaning in the intertidal zone of exposed sandy beaches: Preliminary study of the “Prestige” oil spill

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

The macroinfauna of the Galician sandy beaches (NW Spain) affected by the Prestige oil-spill

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

Macroinfaunal recovery on the beach most severely affected by the ‘Prestige’ oil spill (O Rostro, Galicia, north-west Spain)

P17.35 GEINO-10: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY OF THE CHARACTERISTICS OF PATIENTS WITH INTRA-AXIAL BRAIN TUMOURS AND THEIR THERAPEUTIC MANAGEMENT IN SPANISH HOSPITALS

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

CP-117 Use and effectiveness of firstline chemotherapy regimens in advanced gastric cancer: evolution from 2009 to 2016

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas : benefit for selected patients

First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

P897Sacubitril/valsartan: science-fiction, or current practice?

P3611Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease

Suchergebnisse filtern